Gang Zhang PhD
About Gang Zhang PhD
Gang Zhang, PhD, is a Scientist II at Prothena Corporation plc, where he has worked since 2022. He holds a PhD in Pharmacology and Experimental Neuroscience from the University of Nebraska Medical Center and a Master of Medicine in Cancer Pathology from Peking University.
Work at Prothena
Gang Zhang currently serves as Scientist II at Prothena Corporation plc, a position he has held since 2022. Prior to this role, he worked as Scientist I at the same company from 2020 to 2022. His tenure at Prothena has contributed to the company's research and development efforts in the biotechnology sector, focusing on innovative therapies.
Education and Expertise
Gang Zhang earned a Bachelor of Medicine (D.D.S. equivalent) from Xi'an Jiaotong University. He then pursued further studies in Cancer Pathology, obtaining a Master of Medicine from Peking University from 2006 to 2009. He continued his education at the University of Nebraska Medical Center, where he completed a Doctor of Philosophy (Ph.D.) in Pharmacology and Experimental Neuroscience from 2009 to 2014.
Background
Gang Zhang has a diverse academic and professional background in the fields of medicine and neuroscience. He began his career with foundational studies in stomatology before transitioning to cancer pathology and pharmacology. His postdoctoral research at the University of California, San Diego, from 2014 to 2019, further solidified his expertise in experimental neuroscience.
Previous Experience
Before his current role at Prothena, Gang Zhang worked as a Scientist at Gladstone Institutes for 11 months in 2019 to 2020. His experience also includes a five-year postdoctoral position at the University of California, San Diego, where he conducted research that contributed to advancements in neuroscience.